ArticleBMC pregnancy and childbirth2026
Independent and synergistic effects of OGTT-based hyperglycemia phenotypes and gestational weight gain on feto-maternal outcomes in GDM.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundGestational weight gain (GWG) and hyperglycemia identified via the oral glucose tolerance test (OGTT) are critical factors influencing adverse pregnancy outcomes. However, the applicability of universal management standards for these factors across specific patient populations remains a subject of critical clinical inquiry. The objective of this study is to examine the independent and synergistic effects of different OGTT-based hyperglycemia phenotypes and GWG on adverse feto-maternal outcomes in women with GDM.
methodsFrom a total cohort of 52,942 parturients, this study included 5,593 cases of GDM after applying exclusion criteria. Participants were classified based on 75-g OGTT results and GWG categories. We systematically performed univariate analysis, multivariate logistic regression analysis, and interaction analysis to explore the associations between OGTT-based hyperglycemia phenotypes, GWG groups, and the incidence of adverse feto-maternal outcomes.
resultsThe incidence of adverse outcomes differed significantly by hyperglycemia phenotypes and GWG categories. Importantly, interaction analysis revealed that the impact of GWG on adverse outcomes varied significantly across different hyperglycemia phenotypes. The risks of preeclampsia, hyperlipidemia, polyhydramnios, large for gestational age infants, and cesarean section were highest in the combined hyperglycemia phenotype.
conclusionsOur findings indicate phenotype-specific epidemiological associations with feto-maternal outcomes. Given the retrospective nature of this study, these observational data are strictly hypothesis-generating. They raise the hypothesis that exploring refined GWG targets-particularly for the isolated fasting hyperglycemia phenotype-warrants future prospective investigation. Furthermore, inadequate GWG was associated with a higher risk of preterm birth exclusively in the isolated post-load hyperglycemia phenotype, indicating a specific correlational trend that merits further exploratory research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.